AI Chatbot Education for Improving HPV Knowledge Among University Students (AIHPV)
Effect of an AI Chatbot-Based Educational Program on HPV Knowledge Among University Students
研究概览
详细说明
Study Purpose
The purpose of this study was to evaluate the effectiveness of an AI chatbot-based educational program in improving Human Papillomavirus (HPV) knowledge among undergraduate nursing students.
Study Design
This study was designed as a parallel-group randomized controlled trial conducted among undergraduate nursing students at Cyprus International University, Northern Cyprus. Participants were randomly assigned to either the intervention group (AI chatbot-based personalized education) or the control group (standard written educational materials) using block randomization.
Sample Size
Based on a previous educational intervention study and the two-sample mean comparison formula, with a significance level of 0.05 and a statistical power of 80%, the required sample size was calculated as 30 participants per group. After allowing for a 10% dropout rate, a total of 68 participants were enrolled, with 34 participants allocated to each study group.
Data Collection Tools
Data were collected using:
A demographic questionnaire (age, gender, faculty, year of study, previous HPV education, source of HPV information, and HPV vaccination status).
The validated 29-item HPV Knowledge Questionnaire developed , assessing general HPV knowledge, HPV testing knowledge, and HPV vaccination knowledge.
Intervention
Participants were randomly assigned to one of two groups.
AI Chatbot Group:
Participants received personalized HPV education through an artificial intelligence (AI) chatbot. Educational content was tailored according to each participant's baseline HPV knowledge and included information on HPV transmission, risk factors, HPV-related diseases, vaccination, prevention strategies, and common misconceptions.
Control Group:
Participants received standard written educational materials covering the same HPV-related topics without chatbot interaction or personalized educational content.
Outcome Assessment
HPV knowledge was measured before and after the educational intervention using the validated HPV Knowledge Questionnaire.
Ethical Considerations
The study received approval from the Cyprus International University Ethics Review Board (Approval No. EKK25-26/15/08). The study was conducted in accordance with the Declaration of Helsinki, and written informed consent was obtained from all participants before enrollment.
Statistical Analysis
Data will be analyzed using SPSS version 26. Descriptive statistics, independent t-tests, paired t-tests, Chi-square tests, Fisher's exact tests, and non-parametric tests will be performed as appropriate. Statistical significance will be be set at a two-sided P value of less than 0.05.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
North Cyprus
-
Nicosia、North Cyprus、塞浦路斯
- Pouran Varvani Farahani
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- All students, both female and male, first semester of bachelor's degree, studying in nursing department Enrollment at Cyprus International University
- Willingness to participate and provide written informed consent
- No prior formal education on HPV
Exclusion Criteria:
- Withdrawal of consent at any stage of the study
- Failure to complete either the pre-test or post-test assessments
- Incomplete participation in the educational intervention
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:AI Chatbot-Based Education
Participants in this group received personalized education about Human Papillomavirus (HPV) through an artificial intelligence (AI) chatbot.
The educational content was tailored according to each participant's baseline HPV knowledge and covered HPV transmission, risk factors, HPV-related diseases, HPV vaccination, prevention strategies, and common misconceptions
|
Participants received personalized education through an artificial intelligence (AI) chatbot.
Educational content was tailored according to each participant's baseline HPV knowledge and included information on HPV transmission, risk factors, HPV-related diseases, HPV vaccination, prevention strategies, and common misconceptions.
The chatbot provided interactive, personalized educational support throughout the intervention
|
|
有源比较器:Standard Written Education
Participants in this group received standard written educational materials covering the same HPV-related topics, including HPV transmission, risk factors, HPV-related diseases, HPV vaccination, and prevention strategies.
No personalized feedback or AI chatbot interaction was provided
|
Participants received standard written educational materials covering HPV transmission, risk factors, HPV-related diseases, HPV vaccination, and prevention strategies.
The educational materials were identical in content to the intervention group but were provided without personalization or AI chatbot interaction
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
HPV Knowledge Score
大体时间:Baseline (before the educational intervention) and 1 month after completion of the educational intervention.
|
The primary outcome measure assesses changes in participants' knowledge of Human Papillomavirus (HPV) following the educational intervention.
HPV knowledge is measured using the validated 29-item HPV Knowledge Questionnaire developed by Waller et al. (2013).
The questionnaire evaluates three domains: general HPV knowledge, HPV testing knowledge, and HPV vaccination knowledge.
Higher total scores indicate greater HPV-related knowledge
|
Baseline (before the educational intervention) and 1 month after completion of the educational intervention.
|
合作者和调查者
调查人员
- 首席研究员:Pouran Varvani Farahani, PhD、PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- PVF-HPV-AI-2026
- EKK25-26/15/08 (其他标识符:Cyprus International University Ethics Review Board)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.